Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-18 4:15 pm Sale | 2025-02-13 | 13G | Edesa Biotech, Inc. EDSA | Thomas A. Satterfield, Jr. | 0 0.000% | -232,161![]() (Position Closed) | Filing History |
2025-02-12 08:02 am Sale | 2024-12-31 | 13G | OS Therapies Incorporated OSTX | Thomas A. Satterfield, Jr. | 1,267,465 5.900% | -27,524![]() (-2.13%) | Filing History |
2025-02-12 08:02 am Purchase | 2024-12-31 | 13G | inTEST Corporation INTT | Thomas A. Satterfield, Jr. | 805,000 6.500% | 135,000![]() (+20.15%) | Filing History |
2025-02-12 08:01 am Purchase | 2024-12-31 | 13G | Ark Restaurants Corp. ARKR | Thomas A. Satterfield, Jr. | 574,251 15.900% | 38,694![]() (+7.23%) | Filing History |
2025-02-12 08:00 am Purchase | 2024-12-31 | 13G | Scientific Industries, Inc. SCND | Thomas A. Satterfield, Jr. | 1,138,055 9.900% | 192,430![]() (+20.35%) | Filing History |
2025-02-12 08:00 am Purchase | 2024-12-31 | 13G | Edesa Biotech, Inc. EDSA | Thomas A. Satterfield, Jr. | 232,161 6.700% | 56,117![]() (+31.88%) | Filing History |
2025-02-12 08:00 am Purchase | 2024-12-31 | 13G | Curis, Inc. CRIS | Thomas A. Satterfield, Jr. | 790,432 9.100% | 100,000![]() (+14.48%) | Filing History |
2025-02-12 08:00 am Purchase | 2024-12-31 | 13G | BioCardia, Inc. BCDA | Thomas A. Satterfield, Jr. | 388,147 8.200% | 388,147![]() (New Position) | Filing History |
2025-01-17 4:05 pm Purchase | 2025-01-13 | 13G | Cytosorbents Corporation CTSO | Thomas A. Satterfield, Jr. | 3,998,867 6.560% | 3,998,867![]() (New Position) | Filing History |
2024-11-01 4:35 pm Purchase | 2024-10-30 | 13G | Curis, Inc. CRIS | Thomas A. Satterfield, Jr. | 690,432 8.050% | 690,432![]() (New Position) | Filing History |
2024-09-24 07:00 am Purchase | 2024-09-18 | 13G | inTEST Corporation INTT | Thomas A. Satterfield, Jr. | 670,000 5.350% | 630,539![]() (+1597.88%) | Filing History |
2024-08-28 4:30 pm Purchase | 2024-08-02 | 13G | OS Therapies Incorporated OSTX | Thomas A. Satterfield, Jr. | 1,294,989 6.200% | 1,294,989![]() (New Position) | Filing History |
2024-06-03 4:10 pm Purchase | 2024-05-30 | 13G | Edesa Biotech, Inc. EDSA | Thomas A. Satterfield, Jr. | 176,044 5.470% | 176,044![]() (New Position) | Filing History |
2024-02-14 5:06 pm Purchase | 2023-12-31 | 13G | BioCardia, Inc. BCDA | Thomas A. Satterfield, Jr. | 113,400 7.870% | 37,426![]() (+49.26%) | Filing History |
2024-02-14 5:05 pm Purchase | 2023-12-31 | 13G | Scientific Industries, Inc. SCND | Thomas A. Satterfield, Jr. | 945,625 9.020% | 348,670![]() (+58.41%) | Filing History |
2024-02-14 5:04 pm Purchase | 2023-12-31 | 13G | Safeguard Scientifics, Inc. SFE | Thomas A. Satterfield, Jr. | 2,089,726 12.610% | 230,445![]() (+12.39%) | Filing History |
2024-02-14 5:02 pm Sale | 2023-12-31 | 13G | Ark Restaurants Corp. ARKR | Thomas A. Satterfield, Jr. | 535,557 14.860% | -15,000![]() (-2.72%) | Filing History |
2024-02-14 4:19 pm Purchase | 2023-12-31 | 13G | Alico, Inc. ALCO | Thomas A. Satterfield, Jr. | 573,410 7.520% | 53,600![]() (+10.31%) | Filing History |
2023-08-07 07:30 am Purchase | 2023-07-28 | 13G | BioCardia, Inc. BCDA | Thomas A. Satterfield, Jr. | 75,974 5.600% | 75,974![]() (New Position) | Filing History |
2023-02-10 5:00 pm Purchase | 2022-12-31 | 13G | Safeguard Scientifics, Inc. SFE | Thomas A. Satterfield, Jr. | 1,859,281 11.390% | 181,671![]() (+10.83%) | Filing History |